INDV — Indivior Pharmaceuticals, Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSuper Stock

Annual cashflow statement for Indivior Pharmaceuticals,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	C2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	10-K
Standards:	IFRS	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	213	-44	-129	2	210
Depreciation
Deferred Taxes
Non-Cash Items	-21	11	173	40	56
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	139	118	-294	-41	-257
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	353	-4	-300	36	-27
Capital Expenditures	-34	-5	-53	-31	-67
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	20	-217	-42	100	1
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-14	-222	-95	69	-66
Financing Cash Flow Items	—	-10	-22	-24	-4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-94	-101	-64	-102	-30
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	244	-328	-458	3	-124